Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BELSOMRA safely and effectively. See full prescribing information for BELSOMRA. BELSOMRA® (suvorexant) tablets, for oral use, C-IV Initial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-prescription
BELSOMRA® (suvorexant) is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.
- generic_name
- suvorexant
- product_names
- suvorexant
- ndc
- 0006-0005, 0006-0005-10, 0006-0005-30, 0006-0005-13, 0006-0033, 0006-0033-10, 0006-0033-30, 0006-0033-13, 0006-0325, 0006-0325-10, 0006-0325-30, 0006-0325-13, 0006-0335, 0006-0335-10, 0006-0335-30, 0006-0335-13
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en